Your browser doesn't support javascript.
loading
Stratification of obesity phenotypes to optimize future therapy (SOPHIA).
Tahrani, Abd A; Panova-Noeva, Marina; Schloot, Nanette C; Hennige, Anita M; Soderberg, Jeannette; Nadglowski, Joe; Tarasenko, Lisa; Ahmad, Nadia N; Sleypen, Barbara Sc; Bravo, Rafael; Al-Najim, Werd; le Roux, Carel W.
  • Tahrani AA; Novo Nordisk A/S, søborg, Denmark.
  • Panova-Noeva M; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Schloot NC; Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Hennige AM; Boehringer Ingelheim International GmbH, Biberach, Germany.
  • Soderberg J; JDRF International.
  • Nadglowski J; Obesity Action Coalition, Tampa, FL.
  • Tarasenko L; Pfizer Inc, New York, NY, USA.
  • Ahmad NN; Eli Lilly and Company, Indianapolis, IN, USA.
  • Sleypen BS; Medtronic (Covidien AG).
  • Bravo R; Novo Nordisk A/S, søborg, Denmark.
  • Al-Najim W; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
  • le Roux CW; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
Expert Rev Gastroenterol Hepatol ; 17(10): 1031-1039, 2023.
Article en En | MEDLINE | ID: mdl-37791820

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estilo de Vida / Obesidad Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estilo de Vida / Obesidad Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article